Associations with LVH
| Unadjusted | Adjusted | |||
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | 1.03 (1.00 to 1.05) | 0.038 | 1.01 (0.98 to 1.04) | 0.724 |
| Sex | 1.07 (0.59 to 1.93) | 0.828 | 0.98 (0.48 to 1.99) | 0.957 |
| Hypertension | 0.81 (0.39 to 1.66) | 0.561 | 0.93 (0.40 to 2.19) | 0.872 |
| Hyperlipidaemia | 0.87 (0.49 to 1.58) | 0.654 | 0.69 (0.33 to 1.44) | 0.324 |
| Diabetes | 0.99 (0.44 to 2.24) | 0.975 | 0.93 (0.36 to 2.42) | 0.881 |
| Coronary artery disease | 1.50 (0.70 to 3.21) | 0.293 | 1.17 (0.45 to 3.03) | 0.752 |
| Atrial fibrillation | 2.10 (1.02 to 4.33) | 0.044 | 1.72 (0.74 to 4.02) | 0.210 |
| Creatinine | 2.22 (1.04 to 4.76) | 0.040 | 2.20 (1.04 to 4.68) | 0.040 |
| CAA pattern | 1.55 (0.82 to 2.94) | 0.179 | 1.90 (0.78 to 4.66) | 0.161 |
| HTN-cSVD pattern | 4.53 (2.32 to 8.83) | <0.001 | 7.38 (2.84 to 19.20) | <0.001 |
| Mixed NHIM | 2.06 (0.76 to 5.57) | 0.157 | 4.45 (1.25 to 15.90) | 0.019 |
This table shows univariate and multivariable associations between predictor variables and LVH.
CAA, cerebral amyloid angiopathy; HTN-cSVD, hypertensive cerebral small vessel disease; LVH, left ventricular hypertrophy; NHIM, non-haemorrhagic imaging markers.